Stay updated on Eli Lilly and Company Press Releases
Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest updates to the Eli Lilly and Company Press Releases page
- Check3 days agoChange DetectedThe website now includes a security verification step for users, indicating a heightened focus on connection security, while extensive privacy-related content has been removed.SummaryDifference100%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedEli Lilly has made significant updates, including new privacy preferences for user data collection, multiple product approvals such as Zepbound® for sleep apnea and Kisunla™ for Alzheimer's in China, and a $15 billion share repurchase program.SummaryDifference100%
- Check25 days agoChange DetectedA new addition (8f59ab0acb042f36) has been made, while an existing item (8f1e17e569502f3c) has been removed.SummaryDifference7%
- Check32 days agoChange DetectedA new addition with ID 8f1e17e569502f3c has been made, while the item with ID 8ee3a6c5accf69da has been removed.SummaryDifference7%
- Check39 days agoChange DetectedThe website now includes a security verification step for users, indicating a heightened focus on connection security, while extensive privacy-related content has been removed.SummaryDifference100%
- Check53 days agoChange DetectedEli Lilly has announced significant updates, including the election of Jon Moeller to its board of directors and promising results from clinical studies on muvalaplin and tirzepatide, which show potential benefits for cardiovascular health and heart failure management.SummaryDifference100%
Stay in the know with updates to Eli Lilly and Company Press Releases
Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.